药店
医药制造业
药物基因组学
药学保健
制药工业
医疗保健
3D打印
业务
制药技术
医学
工程类
药理学
护理部
政治学
机械工程
法学
化学
色谱法
作者
Klaudia Englezos,Lingxin Wang,Edwin C.K. Tan,Lifeng Kang
标识
DOI:10.1016/j.ijpharm.2023.122785
摘要
The current healthcare dynamic has shifted from one-size-fits-all to patient-centred care, with our increased understanding of pharmacokinetics and pharmacogenomics demanding a switch to more individualised therapies. As the pharmaceutical industry remains yet to succumb to the push of a technological paradigm shift, pharmacists lack the means to provide completely personalised medicine (PM) to their patients in a safe, affordable, and widely accessible manner. As additive manufacturing technology has already established its strength in producing pharmaceutical formulations, it is necessary to next consider methods by which this technology can create PM accessible from pharmacies. In this article, we reviewed the limitations of current pharmaceutical manufacturing methods for PMs, three-dimensional (3D) printing techniques that are most beneficial for PMs, implications of bringing this technology into pharmacy practice, and implications for policy surrounding 3D printing techniques in the manufacturing of PMs.
科研通智能强力驱动
Strongly Powered by AbleSci AI